title: Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.
abstract: This review is one of two complementary reviews that have been prepared in the framework of the Eurogin Roadmap 2015 to evaluate how knowledge about HPV is changing practices in HPV infection and disease control through vaccination and screening. In this review of HPV vaccine knowledge, we present the most significant findings of the past year which have contributed to our knowledge of the two HPV prophylactic vaccines currently in widespread use and about the recently licensed nonavalent HPV vaccine. Whereas anal cancer is dealt with in the companion mini-review on screening, we also review here the rapidly evolving evidence regarding HPV-associated head and neck cancer and priority research areas.
authors.affiliation: National HPV Vaccination Program Register, VCS Registries, East Melbourne, Vic, Australia.|School of Population and Global Health, University of Melbourne, Vic, Australia.
authors.forename: Julia M L
authors.initials: JM
authors.lastname: Brotherton
authors.affiliation: Modelling and Economics Unit, Public Health England, London, United Kingdom.|Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
authors.forename: Mark
authors.initials: M
authors.lastname: Jit
authors.affiliation: Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM.
authors.forename: Patti E
authors.initials: PE
authors.lastname: Gravitt
authors.affiliation: Département de Médecine Sociale et Préventive, Université Laval, Québec, QC, Canada.
authors.forename: Marc
authors.initials: M
authors.lastname: Brisson
authors.affiliation: Infections & Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD.
authors.forename: Aimée R
authors.initials: AR
authors.lastname: Kreimer
authors.affiliation: Department of Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA.
authors.forename: Sara I
authors.initials: SI
authors.lastname: Pai
authors.affiliation: Department of Otolaryngology Head and Neck Surgery, Johns Hopkins School of Medicine, Johns Hopkins Outpatient Center, Baltimore, MD.
authors.forename: Carole
authors.initials: C
authors.lastname: Fakhry
authors.affiliation: Institut du Col, 174 Rue de Courcelles, Paris, 75017, France.
authors.forename: Joseph
authors.initials: J
authors.lastname: Monsonego
authors.affiliation: International Agency for Research on Cancer, 69372 Lyon cedex 08, France.
authors.forename: Silvia
authors.initials: S
authors.lastname: Franceschi
mesh_terms: D005060:Europe / Q000453:epidemiology; D005260:Female; D006258:Head and Neck Neoplasms / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D008297:Male; D008403:Mass Screening; D009369:Neoplasms / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D017063:Outcome Assessment, Health Care; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000145:classification / Q000276:immunology*; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000209:etiology* / Q000473:pathology / Q000517:prevention & control*; D014611:Vaccination
chemical_list: D053918:Papillomavirus Vaccines
keywords: HPV; cervical cancer; oropharyngeal cancer; vaccine